Castro-Amorim J, Pinto A, Mukherjee A, Ramos M, Fernandes P
Chem Sci. 2025; 16(4):1974-1985.
PMID: 39759936
PMC: 11694569.
DOI: 10.1039/d4sc06511e.
de Oliveira A, Lacerda M, Ramos M, Fernandes P
Toxins (Basel). 2024; 16(2).
PMID: 38393149
PMC: 10893444.
DOI: 10.3390/toxins16020071.
Herbert C, Luies L, Loots D, Williams A
BMC Infect Dis. 2023; 23(1):536.
PMID: 37592227
PMC: 10436461.
DOI: 10.1186/s12879-023-08505-4.
Castro-Amorim J, Novo de Oliveira A, Da Silva S, Soares A, Mukherjee A, Ramos M
J Med Chem. 2023; 66(8):5364-5376.
PMID: 37018514
PMC: 10150362.
DOI: 10.1021/acs.jmedchem.3c00097.
Pundalik S, Hanumappa K, Giresha A, Urs D, Rajashekarappa S, Muniyappa N
J Inflamm Res. 2023; 15:6905-6921.
PMID: 36619941
PMC: 9811966.
DOI: 10.2147/JIR.S383441.
Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A.
Kim R, Chen Z, Mann T, Bastard K, Scott K, Church W
Molecules. 2020; 25(19).
PMID: 32998383
PMC: 7583969.
DOI: 10.3390/molecules25194459.
Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations.
Markovic M, Dahan A, Keinan S, Kurnikov I, Aponick A, Zimmermann E
Pharmaceutics. 2019; 11(4).
PMID: 30995772
PMC: 6523355.
DOI: 10.3390/pharmaceutics11040186.
Lipoquality control by phospholipase A enzymes.
Murakami M
Proc Jpn Acad Ser B Phys Biol Sci. 2017; 93(9):677-702.
PMID: 29129849
PMC: 5743847.
DOI: 10.2183/pjab.93.043.
Structural basis for functional selectivity and ligand recognition revealed by crystal structures of human secreted phospholipase A group IIE.
Hou S, Xu T, Xu J, Qu L, Xu Y, Chen L
Sci Rep. 2017; 7(1):10815.
PMID: 28883454
PMC: 5589937.
DOI: 10.1038/s41598-017-11219-8.
The Roles of the Secreted Phospholipase A Gene Family in Immunology.
Murakami M, Yamamoto K, Miki Y, Murase R, Sato H, Taketomi Y
Adv Immunol. 2016; 132:91-134.
PMID: 27769509
PMC: 7112020.
DOI: 10.1016/bs.ai.2016.05.001.
A new era of secreted phospholipase A₂.
Murakami M, Sato H, Miki Y, Yamamoto K, Taketomi Y
J Lipid Res. 2015; 56(7):1248-61.
PMID: 25805806
PMC: 4479330.
DOI: 10.1194/jlr.R058123.
Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytes.
Lee L, Bryant K, Bouveret R, Lei P, Duff A, Harrop S
J Biol Chem. 2013; 288(21):15269-79.
PMID: 23482564
PMC: 3663547.
DOI: 10.1074/jbc.M112.397893.
An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats.
Iyer A, Lim J, Poudyal H, Reid R, Suen J, Webster J
Diabetes. 2012; 61(9):2320-9.
PMID: 22923652
PMC: 3425408.
DOI: 10.2337/db11-1179.
Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.
Machado-Aranda D, Wang Z, Yu B, Suresh M, Notter R, Raghavendran K
Surgery. 2012; 153(1):25-35.
PMID: 22853859
PMC: 3509248.
DOI: 10.1016/j.surg.2012.05.043.
Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
Mouchlis V, Magrioti V, Barbayianni E, Cermak N, Oslund R, Mavromoustakos T
Bioorg Med Chem. 2011; 19(2):735-43.
PMID: 21216150
PMC: 3050527.
DOI: 10.1016/j.bmc.2010.12.030.
Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor.
Mouchlis V, Mavromoustakos T, Kokotos G
J Comput Aided Mol Des. 2010; 24(2):107-15.
PMID: 20130961
DOI: 10.1007/s10822-010-9319-7.
Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes.
Rosenson R, Gelb M
Curr Cardiol Rep. 2009; 11(6):445-51.
PMID: 19863869
DOI: 10.1007/s11886-009-0064-2.
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease.
Chalbot S, Zetterberg H, Blennow K, Fladby T, Grundke-Iqbal I, Iqbal K
Clin Chem. 2009; 55(12):2171-9.
PMID: 19850632
PMC: 2857971.
DOI: 10.1373/clinchem.2009.130286.
Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.
Cassidy C, Setzer W
J Mol Model. 2009; 16(2):311-26.
PMID: 19603203
DOI: 10.1007/s00894-009-0547-5.
Phospholipase A2 biochemistry.
Burke J, Dennis E
Cardiovasc Drugs Ther. 2008; 23(1):49-59.
PMID: 18931897
PMC: 2823292.
DOI: 10.1007/s10557-008-6132-9.